ViiV Healthcare to present 23 abstracts from innovative HIV treatment and prevention portfolio at EACS 2023
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced the presentation of key abstracts highlighting the breadth of its approved and investigational medicines at the 19th Annual Europ



